期刊文献+

白细胞介素-18mRNA在非小细胞肺癌中的表达及其临床意义 被引量:2

Expression of IL-18mRNA in non-small cell lung cancer and its clinical significance
下载PDF
导出
摘要 目的:检测IL-18mRNA在非小细胞肺癌及癌组织中的表达,探讨其对非小细胞肺癌发生和发展过程的影响。方法:为非小细胞肺癌患者35例,男24例,女11例,年龄42-76岁,平均56岁,其中鳞癌17例(48.57%),腺癌13例(37.14%),腺鳞癌5例(14.29%)。对照组均来自距离肿瘤边缘2-4cm的正常肺组织。肿瘤直径≥4cm者6例(17.14%);肿瘤直径<4cm者29例(82.86%)。用RT-PCR法检测35例肺癌肿瘤组织细胞内和癌旁正常组织中的IL-18mRNA水平的表达。结果:在35例非小细胞肺癌中IL-18mRNA阳性表达率为100%,与癌旁正常组织比较,肺癌IL-18阳性表达率明显增高,差异有统计学意义(P<0.05)。结论:IL-18mRNA在NSCLC发展过程中发挥重要作用,其表达与患者年龄、性别和肿瘤组织类型无明显相关性,而与病理学分级、肿瘤T分期和有无淋巴结转移相关。 Objective:To study the expression of IL-18 expression in non-small cell lung cancer and the relationship with of the occurrence and development of non-small cell lung cancer.Medthods: Of 35 patients with non-small cell lung cancer there were 24 males and 11 females,aged from 42 to 76 years,mean 56,including 17 cases of squamous carcinoma(48.57%),adenocarcinoma in 13 cases(37.14%),adenosquamous carcinoma in 6 cases(14.29%).The control group were normal lung tissue from the tumor margin 2-4cm,tumor diameter ≥ 4cm in 6 cases(17.14%),4cm in 29 cases(82.86%).IL-18 mRNA expression was detected by RT-PCR.Results: IL-18mRNA was positive in 35 cases of non-small cell lung cancer(100%),compared with normal tissue,IL-18 mRNA positive expression was significantly increased,the difference was statistically significant(P〈0.05).Conclusion: IL-18mRNA expression is no correlated with age,gender tumor type,but related with the pathological grade,tumor T stage and lymph node metastasis,IL-18 mRNA in NSCLC plays an important role in the development process.
出处 《现代肿瘤医学》 CAS 2011年第12期2426-2428,共3页 Journal of Modern Oncology
基金 南通大学附属医院基金资助项目(编号:Tdfy0938)
关键词 IL-18 非小细胞肺癌 RT-PCR IL-18 non-small cell lung cancer RT-PCR
  • 相关文献

参考文献5

二级参考文献41

  • 1王淑为,马小彤,徐玢,杨宾霞,段永娟,林永敏.小鼠β-防御素2与白介素18肿瘤疫苗的协同抗白血病作用研究[J].现代免疫学,2009,29(1):40-44. 被引量:3
  • 2杨升.白细胞介素18与肿瘤关系的研究进展[J].福建医药杂志,2005,27(2):148-151. 被引量:2
  • 3陈文芳,张利宁,宋磊,刘志亭,刘应军.重组人白细胞介素-18的纯化、复性及其活性检测[J].中国生物制品学杂志,2005,18(3):238-240. 被引量:1
  • 4齐法莲,徐军,杜秀敏.白细胞介素-18与临床疾病关系的研究(文献综述)[J].放射免疫学杂志,2005,18(5):378-380. 被引量:6
  • 5Coughlin CM, Salhany KE,Wysocka M, et al. Interleukin 12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis [J ]. J Clin Invest, 1998,101 (6) : 1441-1452.
  • 6Miller GM,Kim DW, Andres ML, et al. Changes in the activation and reconstitution of lymphocytes resulting from total -body irradiation correlate with slowed tumor growth[J]. Oncology, 2003,65(3) :229-241.
  • 7Yao NS,Chen YM,Perng RP,et al. Additive effect of Interleukin-12 and Interleukin 18 on the T help cell pathway of malignant pleural effusion[J]. Lung Cancer,2002,180(1): 15-24
  • 8Lissoni P, Brivio F, Rovelli F,et al. Serum concebtrations of In terleukin-18 in early and advanced cancer patients: enhanced se cretion in metastatic disease[J] J Boil Regul Homeost Agents 2000,14(4) :275-257.
  • 9Toshinobu K ,Takashi I, Takashi M, et al. Preoperation serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma[J]. Cancer, 2001,92(8):2050-2055.
  • 10Eisma R J, Spiro JK, Kreutzer DL. Role of angiogenic factors : coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma [ J ]. Laryngoscope, 1999, 109 (5) :687-693.

共引文献32

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部